Antisense Therapeutics Limited (AU:PER) has released an update.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Percheron Therapeutics Limited has requested a trading halt on its securities pending a significant announcement related to a capital raising. This pause in trading aims to ensure the capital raising process is conducted smoothly and is expected to be lifted once the announcement is made or by the start of trading on October 18, 2024.
For further insights into AU:PER stock, check out TipRanks’ Stock Analysis page.